Financing ·
Quoin raises up to $50M in private placement and reports Q3 net loss of $4.9M
QNRXQuoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. announced a private placement financing of up to approximately $50.0 million with healthcare-focused institutional investors, including initial upfront funding of about $30.8 million and potential additional proceeds from warrant exercises. The company also reported financial results for the quarter ended September 30, 2026, showing a net loss of approximately $4.9 million compared to $3.9 million in the prior year period. Cash and equivalents stood at roughly $33.2 million as of quarter-end. Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases.